Efficacy of an Encapsulated Probiotic Bifidobacterium Infantis 35624 in Irritable Bowel Syndrome

Mise à jour : Il y a 5 ans
Référence : NCT00135031

Femme Homme

Extrait

The purpose of this study was to determine the dose-ranging efficacy and safety profile of encapsulated Bifidobacterium infantis 35624 in female subjects with irritable bowel syndrome (IBS).


Critère d'inclusion

  • Irritable bowel syndrome

Liens